Karlsruhe (GER), 16 June 2020
 joimax^®, the German-based market leader in technologies and training methods for full-endoscopic and minimally invasive spinal surgery, is starting as of now a new partnership in Japan. The distributor JMC- JAPAN MEDICALNEXT CO., LTD. and joimax^® are pursuing a long-term sales cooperation that will result in an extensive distribution agreement for the entire Japanese market.

joimax^® is looking forward to working with a partner strong as JMC, says joimax^® Founder and CEO Wolfgang Ries and adds, “a company that has the necessary personnel, expertise, as well as the corresponding specialization and penetration of the market”. Masayuki Yoshimura, President and CEO of JMC, explains, “We are very excited to partner with joimax^®. With our shared vision for advancing the field of minimum invasive spinal surgery, we are looking forward to introducing the globally recognized joimax^® products in Japan”. Thus, joimax^® strengthens its sales activities in Japan and enters into another important partnership in Asia.

JAPAN MEDICALNEXT CO., LTD. founded in 1992 is located in Osaka, Japan. With 314 employees at its locations and an Orthopedics Division that will focus on joimax^® products, the company is a wholly-owned entity of MC Healthcare, Inc. (subsidiary of Mitsubishi Corporation) and prominent supplier of medical devices in Japan.

Karlsruhe, GER– April 18, 2019 – joimax^®, the Germany-based market leader of technologies and training methods for full-endoscopic, minimally-invasive spinal surgery, is presenting its complete product portfolio at the 48^th Annual Meeting of the Japanese Society for Spine Surgery and Related Research (JSSR). The annual meeting is currently underway running April 18-20, 2019 in Yokohama, Japan.

Earlier this year, joimax^® announced its partnership with United Biomech Japan, Inc., who is overseeing distribution of the complete joimax^® product line throughout Japan. Approval of the Pharmaceutical Medicals and Medical Devices Agency (PMDA) is expected within the next couple of months.

“The Japanese market is characterized by a strong demand for innovative products on endoscopic spinal surgery,” explained United Biomech Japan, Inc. Executive Kazuya Oribe. “The interest at our booth is overwhelming. There are approximately one thousand Japanese surgeons that are now already interested in doing endoscopic spinal surgery.”

“The patients’ demand for gentle surgery methods that result in a very quick recovery, is continuously increasing,” said joimax^® Group Founder and CEO Wolfgang Ries. “Our entrance into the Japanese market is another milestone in expanding our global presence to offer superior medical products. Coupled with an outstanding, international training and education program, we’ve positioned ourselves for long-term growth.”